Replies to post #270690 on Amarin Corp Plc (AMRN)

[Exgermanowner]

I knew about the trial but never looked it up. It's disappointing V is only in one cohort group. The dosage is really low as well. I wouldn't have a clue as to why that specific combination and dosage.

[rafunrafun]

LEAKED TRANSCRIPT:


Gilead to Amarin: We like you guys, can we test your drug in our NASH trial?

Amarin: Sure.

Gilead: We would like to buy you guys but you have an overhang with the patent.

Amarin: Can you help?

Gilead: Here is our old attorney who has previously won for us in the AC:

HC Wainwright reiterates Buy, notes addition of noted atty who was part of team that won appeal "on behalf of Gilead Sciences (GILD) regarding the hepatitis C drug sofosbuvir, in which the judge overturned a $2.5B jury verdict and the Federal Circuit affirmed"

HC Wainwright reiterates Buy, notes addition of noted atty who was part of team that won appeal "on behalf of Gilead Sciences (GILD) regarding the hepatitis C drug sofosbuvir, in which the judge overturned a $2.5B jury verdict and the Federal Circuit affirmed" $AMRN https://t.co/6B0w25rv5c

— TerraPharma (@TerraPharma1) May 1, 2020

Amarin: Thanks. $25 + $25 CVR?

Gilead: $15 + $15 CVR?

Amarin: $20 + 20 CVR?

Gilead: Deal.

Amarin: Deal. Let's now have fun and announce it when it is least expected.

:-)